Psoriasis therapy holds promise for treating atherosclerosis: study
The findings reinforce the importance of treating inflammation, including of the skin, say researchers
Biologic therapy in patients with severe psoriasis is associated with significant improvements in coronary-artery plaque characteristics, according to new research.
Lead author Dr Nehal Mehta from the National Heart, Lung and Blood Institute in Maryland, US, says the anti-inflammatory effects of biologic therapies hold promise for the treatment of atherosclerosis, but more research is needed.
Severe psoriasis is associated with an elevated risk of early MI and rates of coronary-artery disease similar to those in type 2 diabetes.
However, whether biologic therapy alters coronary-artery characteristics is unknown.
